Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “lung cancer”

JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C MutationRecruiting
NCT06416410Phase 3Updated Aug 13, 2026
Sponsor: Allist Pharmaceuticals, Inc.
Advanced Non-squamous Non-small-cell Lung Cancer · Metastatic Non-squamous Non Small Cell Lung Cancer
China
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung CancerRecruiting
NCT05198830Phase 2Updated Aug 13, 2026
Sponsor: National Cancer Institute (NCI)
Lung Adenocarcinoma · Lung Large Cell Carcinoma · Lung Non-Squamous Non-Small Cell Carcinoma · Stage III Lung Cancer AJCC v8
United States
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung CancerTerminated
NCT02769962Phase 1, Phase 2Updated Aug 13, 2026
Sponsor: National Cancer Institute (NCI)
Urothelial Carcinoma · Urothelial Cancer · Lung Neoplasms · Small Cell Lung Cancer
United States
A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung CancerRecruiting
NCT06863233Phase 1Updated Aug 13, 2026
Sponsor: Memorial Sloan Kettering Cancer Center
Lung Cancer · Non Small Cell Lung Cancer · Metastatic Non Small Cell Lung Cancer
United States
Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q MutationRecruiting
NCT06956001Phase 3Updated Aug 13, 2026
Sponsor: Allist Pharmaceuticals, Inc.
EGFR · NSCLC (Advanced Non-small Cell Lung Cancer)
China
Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung CancerRecruiting
NCT07251582Phase 3Updated Aug 13, 2026
Sponsor: Hunan Province Tumor Hospital
Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC)
China
Study to Assess GTAEXS617 in Participants With Advanced Solid TumorsRecruiting
NCT05985655Phase 1, Phase 2Updated Aug 13, 2026
Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
Head and Neck Squamous Cell Carcinoma (HNSCC) · Pancreatic Adenocarcinoma · Non-small Cell Lung Cancer (NSCLC) · Platinum-resistant High-grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers (HGSOC)
United States, Belgium, United Kingdom
To Assess the Efficacy and Safety of Furmonertinib Versus Placebo, in Patients With Epidermal Growth Factor Receptor Mutation Positive Stage II-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant ChemotherapyRecruiting
NCT04853342Phase 3Updated Aug 13, 2026
Sponsor: Allist Pharmaceuticals, Inc.
Non-small Cell Lung Carcinoma
China
A Study of Lorlatinib in Combination With Ramucirumab in People With Lung CancerActive Not Recruiting
NCT06007937Phase 1, Phase 2Updated Aug 13, 2026
Sponsor: Memorial Sloan Kettering Cancer Center
Non Small Cell Lung Cancer · Metastatic · Recurrent
United States
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung CancerRecruiting
NCT06712316Phase 2, Phase 3Updated Aug 13, 2026
Sponsor: BioNTech SE
Non-small Cell Lung Cancer
United States, Australia, Belgium, Brazil, Bulgaria +15 more
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung CancerRecruiting
NCT02133196Phase 2Updated Aug 13, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Non-Small Cell Lung Cancer · Squamous Cell Carcinoma · Advanced NSCLC · Adenosquamous Carcinoma
United States
Evaluating the Impact of CONNECT in a Multilingual PopulationRecruiting
NCT07111936NAUpdated Aug 13, 2026
Sponsor: University of California, San Francisco
Smoking Cessation · Smoking Cessation Counseling Ability and Practice · Smoking Cessation Counselling · Lung Cancer Screening
United States
A Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation in ChinaActive Not Recruiting
NCT05009329Phase 1, Phase 2Updated Aug 13, 2026
Sponsor: Allist Pharmaceuticals, Inc.
NSCLC · Solid Tumor
China
Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)Recruiting
NCT06228066Phase 2Updated Aug 13, 2026
Sponsor: National Cancer Institute (NCI)
Small Cell Carcinoma of the Bladder · High Grade Neuroendocrine Tumors of the Urinary Tract
United States
Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung CancerWithdrawn
NCT07353957Phase 2Updated Aug 13, 2026
Sponsor: Merus B.V.
Lung Cancer - Non Small Cell Squamous · Lung Cancer - Non Small Cell Non-Squamous
United States, Australia, France, Italy, Netherlands +2 more
A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced MalignanciesActive Not Recruiting
NCT06120075Phase 1Updated Aug 13, 2026
Sponsor: Arcus Biosciences, Inc.
Advanced Cancer
United States
Collection of Blood From Patients With CancerRecruiting
NCT00034216N/AUpdated Aug 13, 2026
Sponsor: National Cancer Institute (NCI)
Prostate Cancer · Breast Cancer · Colon Cancer · Lung Cancer
United States
Paclitaxel Therapeutic Drug Monitoring in Cancer PatientsSuspended
NCT03987555N/AUpdated Aug 13, 2026
Sponsor: Wake Forest University Health Sciences
Solid Tumor, Adult · Metastatic Nonsmall Cell Lung Cancer · Anatomic Stage IV Breast Cancer AJCC v8 · Metastatic Cervical Carcinoma
United States
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 InhibitorsActive Not Recruiting
NCT05671510Phase 3Updated Aug 13, 2026
Sponsor: OncoC4, Inc.
Non Small Cell Lung Cancer
United States, Australia, Belgium, Canada, China +7 more
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)Recruiting
NCT07154290Phase 2Updated Aug 13, 2026
Sponsor: Regeneron Pharmaceuticals
Non-Small Cell Lung Cancer · Advanced Non-Small Cell Lung Cancer · Metastatic Non-Small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung
United States
Molecular Diagnosis of Lung Cancer Via Bronchoscopy: The Significance of Bronchial Liquid Biopsy (ctDNA and ctRNA)Completed
NCT06228508N/AUpdated Aug 13, 2026
Sponsor: Assistance Publique - Hôpitaux de Paris
Non Small Cell Lung Cancer
France
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)Recruiting
NCT06692738Phase 3Updated Aug 13, 2026
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +21 more
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE TrialRecruiting
NCT06096844Phase 3Updated Aug 13, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Lung Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8 · Stage IIIC Lung Cancer AJCC v8 · Stage IV Lung Cancer AJCC v8
United States
Real-World Outcomes of Resected EGFR-Mutated NSCLC Patients Treated With Adjuvant EGFR-TKI in ChinaRecruiting
NCT07593248N/AUpdated Aug 13, 2026
Sponsor: AstraZeneca
Lung Cancer
China
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AST2303 Tablets (ABK3376 Tablets) in Patients With Advanced or Metastatic Non-Small Cell Lung CancerRecruiting
NCT06955988Phase 1Updated Aug 13, 2026
Sponsor: Allist Pharmaceuticals, Inc.
Locally Advanced or Metastatic Non-small Cell Lung Cancer
China

Previous page Next page